| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b9dc89cc4ba060cc73bbf0c90bbb78 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate |
1992-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ceb0f8767c067bb508ea1e190f29ace
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a34729b5fcdcfe4c152b3573235c76c5 |
| publicationDate |
1993-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9301809-A1 |
| titleOfInvention |
Pharmaceutical formulations comprised of micronised halofantrine |
| abstract |
Novel formulations of the anti-malarial compound halofantrine and pharmaceutically acceptable salts thereof, having improved bioavailability. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-685263-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9527492-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5968987-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02094223-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02094223-A2 |
| priorityDate |
1991-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |